EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Ferrocenyl Quinoline-Benzimidazole Hybrids: A Multistage Strategy to Combat Drug-Resistant Malaria

Taryn M Golding iD, Larnelle F Garnie, Tayla Rabie, Janette Reader, Lyn-Marié Birkholtz, Kathryn J Wicht iD, Gregory S Smith iD

Inorganic Chemistry · 2025

DOI: 10.1021/acs.inorgchem.5c02689 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Inorganic Chemistry, 2025. Verfasst von Taryn M Golding und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, University of Cape Town, Rondebosch, Cape Town 7701, South Africa. Hauptthemen laut MEDLINE: Benzimidazoles, Plasmodium falciparum, Antimalarials, Quinolines. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 114 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, University of Capetown, National Institute of Allergy and Infectious Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Molecular hybridization and metal incorporation are widely employed strategies for drug development aimed at enhancing pharmacological efficacy while mitigating the emergence of drug resistance. The effectiveness of these approaches is supported by numerous studies demonstrating their success against a range of diseases. Despite the deployment of malaria vaccines, effective treatment remains hindered by the persistent emergence of drug-resistant Plasmodium falciparum strains, contributing to an alarming global disease burden. Inspired by the antimalarial candidate ferroquine, this study focused on the design and synthesis of ferrocenyl-based quinoline-benzimidazole molecular hybrids. The hybrids were evaluated for their in vitro blood-stage antiplasmodial activity against drug-sensitive NF54 and multidrug-resistant K1 P. falciparum strains, exhibiting potent submicromolar activity. Notably, incorporating an N,N-dimethylaminomethyl side chain significantly enhanced activity against both strains. Further assays revealed a compound with multistage antiplasmodial activity, targeting both immature and mature gametocytes. Mechanistic studies implicated the inhibition of hemozoin formation as a key mode of action, supported by in vitro cellular heme fractionation analysis. Additionally, fluorescence assays indicated the generation of reactive oxygen species under oxidative conditions, suggesting a complementary pathway contributing to the compounds' antiplasmodial activity. These findings highlight the potential of ferrocenyl-based molecular hybrids as promising candidates in antiplasmodial drug development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BenzimidazolesPlasmodium falciparumAntimalarialsQuinolinesFerrous CompoundsMetallocenesParasitic Sensitivity TestsDrug ResistanceHumansMolecular StructureStructure-Activity Relationship

Substanzen

BenzimidazolesAntimalarialsQuinolinesFerrous CompoundsMetallocenesquinolineferrocenebenzimidazole

Autor:innen und Institutionen

  • Department of Chemistry, University of Cape Town, Rondebosch, Cape Town 7701, South Africa.
  • Department of Biochemistry, Genetics and Microbiology, Institute for Sustainable Malaria Control, University of Pretoria, Hatfield 0028, South Africa.
  • Department of Biochemistry, Stellenbosch University, Matieland, Stellenbosch 7602, South Africa.
  • Holistic Drug Discovery and Development (H3D) Centre, University of Cape Town, Rondebosch, Cape Town 7701, South Africa.
  • South African Medical Research Council Drug Discovery and Development Research Unit, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Rondebosch, Cape Town 7701, South Africa.

ORCID-Profile: Taryn M Golding, Kathryn J Wicht, Gregory S Smith

Förderung

  • NIAID NIH HHS
  • University of Capetown
  • National Institute of Allergy and Infectious Diseases
  • Medicines for Malaria Venture
  • National Research Foundation
  • University of Pretoria
  • South African Medical Research Council

Zitieren

APA

Golding, T. M., Garnie, L. F., Rabie, T., Reader, J., Birkholtz, L. M., Wicht, K. J., & Smith, G. S. (2025). Ferrocenyl Quinoline-Benzimidazole Hybrids: A Multistage Strategy to Combat Drug-Resistant Malaria. Inorganic Chemistry. https://doi.org/10.1021/acs.inorgchem.5c02689

Vancouver

Golding TM, Garnie LF, Rabie T, Reader J, Birkholtz LM, Wicht KJ, et al. Ferrocenyl Quinoline-Benzimidazole Hybrids: A Multistage Strategy to Combat Drug-Resistant Malaria. Inorganic Chemistry. 2025. doi:10.1021/acs.inorgchem.5c02689

BibTeX
@article{Golding2025,
  author = {Golding, Taryn M and Garnie, Larnelle F and Rabie, Tayla and Reader, Janette and Birkholtz, Lyn-Marié and Wicht, Kathryn J and Smith, Gregory S},
  title = {Ferrocenyl Quinoline-Benzimidazole Hybrids: A Multistage Strategy to Combat Drug-Resistant Malaria},
  journal = {Inorganic Chemistry},
  year = {2025},
  doi = {10.1021/acs.inorgchem.5c02689}
}
Kostenlos starten →